Your account is not claimed yet. You can sign up with ORCID to claim your account.

Iacopo Petrini

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Cancer Stem Cells

Mitochondrial Dna

Top Venues

Cell death & disease

Cell death and differentiation

Università degli Studi di Pisa

Università degli Studi di Pisa (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Pisa Nov 1o 2016

Italy

Senior Researcher :: Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia

Education History

Università degli Studi di Pisa - Mar 30o 2012

Italy

PHD

Publications

Yosuke Yamada, Djeda Belharazem-Vitacolonnna, Hanibal Bohnenberger, Christel Weiß, Naoko Matsui, Mark Kriegsmann, Katharina Kriegsmann, Peter Sinn, Katja Simon-Keller, Gerhard Hamilton, Thomas Graeter, Gerhard Preissler, German Ott, Sebastian Schölch, Naoki Nakajima, Akihiko Yoshizawa, Hironori Haga, Hiroshi Date, Roman K Thomas, Iacopo Petrini, Giuseppe Giaccone, Philipp Ströbel, Alexander Marx
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities. Cell death & disease 13 (11) (2022)
Efrat Katsman, Shari Orlanski, Filippo Martignano, Ilana Fox-Fisher, Ruth Shemer, Yuval Dor, Aviad Zick, Amir Eden, Iacopo Petrini, Silvestro Giovanni Conticello, Benjamin P Berman
Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing. Genome biology 23 (1) (2022)
Harvey R Fernandez, Shreyas M Gadre, Mingjun Tan, Garrett T Graham, Rami Mosaoa, Martin S Ongkeko, Kyu Ah Kim, Rebecca B Riggins, Erika Parasido, Iacopo Petrini, Simone Pacini, Amrita Cheema, Rency Varghese, Habtom W Ressom, Yuwen Zhang, Christopher Albanese, Aykut Üren, Mikell Paige, Giuseppe Giaccone, Maria Laura Avantaggiati
The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer. Cell death and differentiation 25 (7) (2018)